IMD Natural Solutions GmbH
IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives Technologies
IMD Natural Solutions GmbH / Key word(s): Investment Press Release IMD Natural Solutions Receives EUR4 Million Equity Investment from Zhejiang Hisun Pharmaceutical Co., Ltd. for Access to Unique Natural Preservatives Technologies Dortmund, Germany, and Taizhou City, China, August 31, 2015 – IMD Natural Solutions GmbH (INS), a natural product company, today announced a collaboration with Zhejiang Hisun Pharmaceutical Co., Ltd. (Hisun; SHA:600267) under which INS receives a EUR4 million equity investment and provides Hisun access to INS’ unique natural product lead discovery platform for antimicrobials and antioxidants for the food, beverage and personal care industries. Furthermore, INS will benefit from Hisun’s production know-how and capabilities. The investment paves the way for INS to further develop and commercialize its innovative antimicrobial preservation product for use in food, beverage and personal care applications. It is a new, fermentation-based all-natural agent with superior efficacy against yeasts, molds and other microbial strains and has shown bioactivity against microbial organisms that have adapted to current preservative agents. The collaboration provides Hisun access to INS’ natural product databases and technology for the identification and development of suitable active natural ingredients for various life science applications. “The investment by Hisun into INS and our access to Hisun’s production know-how and capabilities are an important step in driving our core product towards market entry,” said Dr. Thomas Henkel, Managing Director of INS. “The combination of INS’s natural product platform and product candidates with Hisun’s production know-how creates a unique platform for the development and commercialization of new, innovative products and thus strengthens our market position and pipeline potential substantially,” said Mr. Bai Hua, President and CEO of Hisun. About IMD Natural Solutions GmbH About Zhejiang Hisun Pharmaceuticals Contact Dr. Thomas Henkel, Managing Director Wei Zhang, Secretary of board 2015-08-31 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
390439 2015-08-31 |